[Quadriplegia, in lepromatous leprosy previously cleared-up, diffuse polyneuritis which appeared in spite of 6 years of follow-up consolidating treatment with Sultirene alone].
D000293:Adolescent; D000328:Adult; D002648:Child; D005500:Follow-Up Studies; D006801:Humans; D007918:Leprosy / Q000150:complications* / Q000188:drug therapy; D008297:Male; D011115:Polyneuropathies / Q000188:drug therapy / Q000209:etiology*; D011782:Quadriplegia / Q000188:drug therapy / Q000209:etiology*; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use*; D013450:Sulfones / Q000627:therapeutic use*; D013792:Thalidomide / Q000627:therapeutic use
D013450:Sulfones; D013792:Thalidomide; D013421:Sulfamethoxypyridazine; D012293:Rifampin
Quadriplégie, dans une lèpre lépromateuse anciennement blanchie, par polynévrite diffuse appraue malgré la poursuite depuis six ans d'un traitement de consolidation par Sultirène seul.